TY - CHAP PY - 2004 DA - 2004// TI - Bone health and osteoporosis BT - A report of the Surgeon General. Rockville, MD ID - ref1 ER - TY - JOUR AU - Melton, L. J. AU - Thamer, R. AU - Ray, N. F. AU - Chan, J. K. AU - Chestnut, C. H. AU - Einhorn, T. A. AU - Johnston, C. C. AU - Raisz, L. G. AU - Silverman, S. L. AU - Siris, E. S. PY - 1997 DA - 1997// TI - Fractures attributable to osteoporosis; Report from the National Osteoporosis Foundation JO - J Bone Miner Res VL - 12 UR - https://doi.org/10.1359/jbmr.1997.12.1.16 DO - 10.1359/jbmr.1997.12.1.16 ID - Melton1997 ER - TY - STD TI - International Osteoporosis Foundation Evidence-based guidelines from societies and associations in Europe. [http://www.iofbonehealth.org/policy-advocacy/europe/guidelines.html] UR - http://www.iofbonehealth.org/policy-advocacy/europe/guidelines.html ID - ref3 ER - TY - CHAP PY - 2003 DA - 2003// TI - Management of osteoporosis BT - National Clinical Guideline 71. Edinburgh ID - ref4 ER - TY - JOUR PY - 2001 DA - 2001// TI - Clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis JO - Endocrine Practice VL - 7 ID - ref5 ER - TY - JOUR PY - 2001 DA - 2001// TI - Osteoporosis Prevention, Diagnosis, and Therapy JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.6.785 DO - 10.1001/jama.285.6.785 ID - ref6 ER - TY - JOUR AU - Cranney, A. AU - Guyatt, G. AU - Griffith, L. AU - Wells, G. AU - Tugwell, P. AU - Rosen, C. PY - 2002 DA - 2002// TI - Meta-analysis of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for post menopausal osteoporosis JO - Endocr Rev VL - 23 UR - https://doi.org/10.1210/er.2001-9002 DO - 10.1210/er.2001-9002 ID - Cranney2002 ER - TY - JOUR AU - Chestnut, C. H. AU - Skag, A. AU - Christiansen, C. AU - Recker, R. AU - Stakkestad, J. A. AU - Hoiseth, A. AU - Felsenberg, D. AU - Huss, H. AU - Gilbride, J. AU - Schimmer, R. C. AU - Delmas, P. D. PY - 2004 DA - 2004// TI - Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis JO - J Bone Min Res VL - 19 UR - https://doi.org/10.1359/JBMR.040325 DO - 10.1359/JBMR.040325 ID - Chestnut2004 ER - TY - JOUR AU - Benner, J. S. AU - Glynn, R. J. AU - Mogun, H. AU - Neumann, P. J. AU - Weinstein, M. C. AU - Avorn, J. PY - 2002 DA - 2002// TI - Long term persistence in use of statin therapy in elderly patients JO - JAMA VL - 288 UR - https://doi.org/10.1001/jama.288.4.455 DO - 10.1001/jama.288.4.455 ID - Benner2002 ER - TY - JOUR AU - Christensen, D. B. AU - Williams, B. AU - Goldberg, H. I. AU - Martin, D. P. AU - Engelberg, R. AU - LoGerfo, J. P. PY - 1997 DA - 1997// TI - Assessing compliance to antihypertensive medication using computer-based pharmacy records JO - Med Car VL - 35 UR - https://doi.org/10.1097/00005650-199711000-00008 DO - 10.1097/00005650-199711000-00008 ID - Christensen1997 ER - TY - JOUR AU - Miller, N. H. PY - 1997 DA - 1997// TI - Compliance with treatment regimens in chronic asymptomatic diseases JO - Am J Med VL - 102 UR - https://doi.org/10.1016/S0002-9343(97)00467-1 DO - 10.1016/S0002-9343(97)00467-1 ID - Miller1997 ER - TY - JOUR AU - Yood, R. A. AU - Emani, S. AU - Reed, J. I. AU - Lewis, B. E. AU - Charpentier, M. AU - Lydick, E. PY - 2003 DA - 2003// TI - Compliance with pharmacologic therapy for osteoporosis JO - Osteoporos Int VL - 14 UR - https://doi.org/10.1007/s00198-003-1502-4 DO - 10.1007/s00198-003-1502-4 ID - Yood2003 ER - TY - JOUR AU - Caro, J. J. AU - Ishak, K. J. AU - Huybrechts, K. F. AU - Raggio, G. AU - Raggio, G. AU - Naujoks, C. PY - 2004 DA - 2004// TI - The impact of compliance with osteoporosis therapy on fracture rates in actual practice JO - Osteoporos Int VL - 15 UR - https://doi.org/10.1007/s00198-004-1652-z DO - 10.1007/s00198-004-1652-z ID - Caro2004 ER - TY - JOUR AU - Papaioannou, A. AU - Ioannidis, G. AU - Adachi, J. D. AU - Sebaldt, R. J. AU - Ferko, N. AU - Puglia, M. AU - Brown, J. AU - Tenenhouse, A. AU - Olszynski, W. P. AU - Boulos, P. AU - Hanley, D. A. AU - Josse, R. AU - Murray, T. M. AU - Petrie, A. AU - Goldsmith, C. H. PY - 2003 DA - 2003// TI - Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database JO - Osteoporos Int VL - 14 UR - https://doi.org/10.1007/s00198-003-1431-2 DO - 10.1007/s00198-003-1431-2 ID - Papaioannou2003 ER - TY - JOUR AU - Segal, E. AU - Tamir, A. AU - Ish-Shalom, S. PY - 2003 DA - 2003// TI - Compliance of osteoporotic patients with different treatment regimens JO - Isr Med Assoc J VL - 5 ID - Segal2003 ER - TY - JOUR AU - Cramer, J. A. AU - Gold, D. T. AU - Silverman, S. L. AU - Lewiecki, E. M. PY - 2007 DA - 2007// TI - A systematic review of persistence and compliance with bisphosphonates for osteoporosis JO - Osteoporos Int VL - 18 UR - https://doi.org/10.1007/s00198-006-0322-8 DO - 10.1007/s00198-006-0322-8 ID - Cramer2007 ER - TY - JOUR AU - Lombas, C. AU - Hakim, C. AU - Zanchetta, J. R. PY - 2001 DA - 2001// TI - Compliance with alendronate treatment in an osteoporosis clinic [Abstract M406] JO - J Bone Miner Res VL - 15 ID - Lombas2001 ER - TY - JOUR AU - McCombs, J. S. AU - Thiebaud, P. AU - McLaughlin-Miley, C. AU - Shi, J. PY - 2004 DA - 2004// TI - Compliance with drug therapies for the treatment and prevention of osteoporosis JO - Maturitas VL - 48 UR - https://doi.org/10.1016/j.maturitas.2004.02.005 DO - 10.1016/j.maturitas.2004.02.005 ID - McCombs2004 ER - TY - JOUR AU - Weycker, D. AU - Macarios, D. AU - Edelsberg, J. AU - Oster, G. PY - 2006 DA - 2006// TI - Compliance with drug therapy for postmenopausal osteoporosis JO - Osteoporosis Int VL - 17 UR - https://doi.org/10.1007/s00198-006-0179-x DO - 10.1007/s00198-006-0179-x ID - Weycker2006 ER - TY - JOUR AU - Brankin, E. AU - Walker, M. AU - Lynch, N. AU - Aspray, T. AU - Lis, Y. AU - Cowell, W. PY - 2006 DA - 2006// TI - The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases JO - Curr Med Res Opin VL - 22 UR - https://doi.org/10.1185/030079906X112688 DO - 10.1185/030079906X112688 ID - Brankin2006 ER - TY - JOUR AU - Cramer, J. AU - Lynch, N. O. AU - Gaudin, A. -. F. AU - Walker, M. AU - Cowell, W. PY - 2006 DA - 2006// TI - The impact of dosing frequency on compliance and persistence with bisphosphonate therapy among post-menopausal women: a comparison of studies in USA, UK and France JO - Clin Therapeut VL - 28 UR - https://doi.org/10.1016/j.clinthera.2006.10.013 DO - 10.1016/j.clinthera.2006.10.013 ID - Cramer2006 ER - TY - JOUR AU - Huybrechts, K. F. AU - Ishak, K. J. AU - Caro, J. J. PY - 2005 DA - 2005// TI - Assessment of compliance with osteoporosis treatment and its consequences in a managed care population JO - Bone VL - 38 UR - https://doi.org/10.1016/j.bone.2005.10.022 DO - 10.1016/j.bone.2005.10.022 ID - Huybrechts2005 ER - TY - JOUR AU - Weycker, D. AU - Macarios, D. AU - Edelberg, J. AU - Oster, G. PY - 2007 DA - 2007// TI - Compliance with osteoporosis drug therapy and risk of fracture JO - Osteoporosis Int VL - 18 UR - https://doi.org/10.1007/s00198-006-0230-y DO - 10.1007/s00198-006-0230-y ID - Weycker2007 ER - TY - JOUR AU - Siris, E. S. AU - Harris, S. T. AU - Rosen, C. J. AU - Barr, C. E. AU - Arvesen, J. N. AU - Abbott, T. A. AU - Silverman, S. PY - 2006 DA - 2006// TI - Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases JO - Mayo Clinic proceedings VL - 81 UR - https://doi.org/10.4065/81.8.1013 DO - 10.4065/81.8.1013 ID - Siris2006 ER - TY - JOUR AU - Van den Boogaard, C. H. A. AU - Breekveldt-Postma, N. S. AU - Borggreve, S. E. AU - Goettsch, W. G. AU - Herings, R. M. PY - 2006 DA - 2006// TI - Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study JO - Curr Med Res Opin VL - 22 UR - https://doi.org/10.1185/030079906X132370 DO - 10.1185/030079906X132370 ID - Van den Boogaard2006 ER - TY - STD TI - Sebaldt RJ, Shane LG, Pham BZ, Cook RJ, Thabane L, Petrie A, Olszynski WP, Hanley DA, Brown J, Adachi JD, Murray T, Josse R, Papaioannou A: Impact of Non-Compliance and Non-Persistence With Daily Bisphosphonates on Longer-Term Effectiveness Outcomes In Patients With Osteoporosis [Poster M423]. 26th ASBMR Annual meeting, Seattle. 1–5 October 2004 ID - ref26 ER - TY - JOUR AU - Sebaldt, R. J. AU - Shane, L. G. AU - Pham, B. AU - Cook, R. AU - Thabane, L. AU - Petrie, A. AU - Olszynski, W. P. AU - Hanley, D. A. AU - Brown, J. AU - Adachi, J. D. AU - Murray, T. AU - Josse, R. AU - Papaioannou, A. PY - 2004 DA - 2004// TI - Longer term effectiveness outcomes of noncompliance and nonpersistence with daily regimen bisphosphonate therapy in patients with osteoporosis treated in tertiary specialist care [Abstract P391SA] JO - Osteoporos Int VL - 15 ID - Sebaldt2004 ER - TY - JOUR AU - Goettsch, W. G. AU - Penning, F. AU - Erkens, J. E. AU - Lynch, N. O. AU - Novak, A. AU - Herings, R. M. C. PY - 2005 DA - 2005// TI - Persistent Bisphosphonate Usage Reduces the Risk of Hospitalizations for Osteoporotic Fractures [Abstract SU388] JO - J Bone Miner Res VL - 20 ID - Goettsch2005 ER - TY - STD TI - Penning van Beest FA, Van den Boogaard , Erkens J, Olsen M, Herings RMC: Loss of treatment benefit due to low compliance with bisphosphonate therapy [Poster P051]. ISPOR 11th Annual International Meeting, Philadelphia. 20–24 May 2006 ID - ref29 ER - TY - CHAP AU - Siris, E. AU - Silverman, S. AU - Abbott, T. AU - Barr, C. AU - Harris, S. AU - Rosen, C. PY - 2005 DA - 2005// TI - Adherence to bisphosphonate therapy: relationship to bone fractures at 24 months in women with post menopausal osteoporosis [Abstract 397] BT - Int Symp on Osteoporosis NOS, Washington DC ID - Siris2005 ER - TY - STD TI - Silverman S, Siris E, Abbott T, Barr C, Harris S, Rosen C: Adherence to bisphosphonate therapy is associated with decreased nonvertebral osteoporosis fracture risk [Poster SU417]. J Bone Mineral Research. 2005, 20 (Suppl 1): ID - ref31 ER - TY - STD TI - Curtis JR, Amonkar MM, Baser O, Barr CE, Saag KG: Osteoporotic women adherent to bisphosphonate therapy have reduced osteoporosis related and total health care costs [Poster SU335]. ASBMR Annual Meeting Philadelphia. 15–19 Sep 2006 ID - ref32 ER - TY - STD TI - Curtis JR, Amonkar MM, Baser O, Barr CE, Saag KG: Adherence to bisphosphonate therapy results in reduced osteoporosis related healthcare utilisation [Poster SU322]. ASBMR Annual Meeting Philadelphia. 15–19 Sep 2006 ID - ref33 ER - TY - STD TI - Harris ST, Siris E, Abbott TA, Barr CE, Rosen CJ: Reduced osteoporotic fracture risk in patients adherent to bisphosphonate therapy [Poster 3–382]. Endocrine Society 87th Annual Meeting, San Diego. 4–7 June 2005 ID - ref34 ER - TY - JOUR AU - Mc Donald, H. P. AU - Garg, A. X. AU - Haynes, R. B. PY - 2002 DA - 2002// TI - Interventions to enhance patient adherence to medication prescriptions: scientific review JO - JAMA VL - 288 UR - https://doi.org/10.1001/jama.288.22.2868 DO - 10.1001/jama.288.22.2868 ID - Mc Donald2002 ER - TY - STD TI - Day L, Osborne R, Hristov E, Wark JD: Evaluation of a patient support program (ActNow) in the treatment of osteoporosis [Poster P46]. ANZBMS Annual Scientific Meeting, Perth. 7–9 September, 2005 ID - ref36 ER - TY - JOUR AU - Sikka, R. AU - Xia, F. AU - Aubert, R. E. PY - 2005 DA - 2005// TI - Estimating medication persistency using administrative claims data JO - Am J Manag Care VL - 11 ID - Sikka2005 ER - TY - JOUR AU - Bailey, K. AU - Ellis, C. AU - Majeed, A. PY - 2002 DA - 2002// TI - Trends in the treatment of osteoporosis and types of drug treatment prescribed in general practice in England and Wales, 1994–1998 JO - Health Statistics Quarterly VL - 16 ID - Bailey2002 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/8/97/prepub UR - http://www.biomedcentral.com/1471-2474/8/97/prepub ID - ref39 ER -